Navigation Links
Microfluidics Introduces Revolutionary Bottom-up Technology as a Platform for Continuous Pharmaceutical Manufacturing
Date:4/21/2010

High Shear Processing Leader Unveils Controlled, Scalable Approach at INTERPHEX 2010 (April 20-22, NYC)

Newton, MA (PRWEB) April 21, 2010 -- At INTERPHEX 2010 (April 20-22, NYC), Microfluidics International Corporation (OTCBB: MFLU), the gold standard in pharmaceutical nanomaterials processing, will introduce Microfluidics Reaction Technology™ (MRT) as a cutting-edge platform for continuous pharmaceutical manufacturing. Combining a unique high shear fluid processor with expert process development, MRT is a revolutionary technology for bottom-up nanoparticle creation:

 
  • Continuous crystallization for production of highly crystalline drug nanoparticles
  • Multiphase chemical reactions
  • Nanoencapsulation of actives
  • Process intensification

MRT enables companies to transform their manufacturing processes from batch to continuous in order to drastically reduce the time and cost of commercial drug production. By creating nanoparticles bottom-up and controlling their growth, MRT allows research teams to create stable and consistent nanoemulsions, for example, at previously unattainable sizes and narrow distributions (e.g. Azithromycin with a z-average particle size of 82 nm).

Microfluidics will describe the technology in greater detail at its press conference on Wednesday, April 21, 8:30 AM, at INTERPHEX 2010, Jacob K. Javits Convention Center in New York City. POWREX Corporation, the exclusive distributor of Microfluidics technology in Japan, will also speak at the press event on bringing MRT to Asia.

“According to an independent 2010 survey that we commissioned, 80 percent of pharmaceutical companies plan to invest in continuous crystallization technology,” said Michael C. Ferrara, President and CEO of Microfluidics. “MRT is the technology they are seeking. It has the potential to revolutionize pharmaceutical production by serving as a scalable platform for continuous manufacturing and by enabling pharma companies to make purer, more consistent drugs faster with improved stability and bioavailability.”

The technology has immediate value in the pharmaceutical, biotechnology and energy industries. Some of the applications ideal for MRT include more effective and tailored drugs, more efficient catalysts for fuel cells, and nanomaterials for batteries, photovoltaics and supercapacitors.

"MRT allows companies to improve bioavailability, target delivery and encapsulate actives more efficiently than any top-down process or traditional crystallization method," said Thomai “Mimi” Panagiotou, PhD., Microfluidics Chief Technology Officer. “Currently, the typical batch crystallization process involves several steps, often in locations across the country, which can take weeks. MRT simplifies the process and has been proven to reduce production time to a matter of hours. Its innovative capabilities for continuous crystallization and chemical reactions have the potential to transform the manufacture of drugs and chemicals by significantly streamlining the steps, timing and cost of consistent, continuous large-scale commercial production.”

To learn more about MRT attend the Microfluidics INTERPHEX press conference, visit the company’s Interphex Booth #2214 or contact Kris Sarajian at ksarajian(at)mfics(dot)com or (+1) 617.969.5452 x233.

ABOUT MICROFLUIDICS
Microfluidics (OTCBB: MFLU) is the exclusive producer of Microfluidizer® high shear fluid processors for uniform particle size reduction, robust cell disruption and bottom-up nanoparticle creation. Used primarily by pharmaceutical, biotechnology, chemical, cosmetic, nutraceutical/food and energy companies to research, develop and improve products with efficient processes, more than 3,000 Microfluidizer processors are installed at customer sites in 50 countries around the world. The innovative Microfluidics Technology Center, located at the company’s headquarters outside Boston, Mass., is staffed by expert engineers with a wide range of nanotechnology and application experience for Proof of Concept and Process Development services.
By producing smaller particle sizes and a more narrow distribution than other technologies, with scaleup from lab to production guaranteed, Microfluidics enables companies to create tiny particles that achieve big results. To learn more, visit www.microfluidicscorp.com.

Contact:
Kris Sarajian
Microfluidics International Corporation
617-9695452 ext. 233
ksarajian(at)mfics(dot)com

Editorial Contact:
Barbara Rudolph   
Rudolph Communications, LLC
781-229-1811
bjr(at)rudolphcommunications(dot)com

# # #

Read the full story at http://www.prweb.com/releases/nanotechmanufacturing/nanotechnology/prweb3888574.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Marriage of microfluidics and optics could advance lab-on-a-chip devices
2. Microfluidics Chairman James N. Little, Ph.D., Announces Retirement from Board of Directors
3. Microfluidics International Corporation Announces Third Quarter 2009 Financial Results
4. Microfluidics International Corporation to Report Third Quarter 2009 Financial Results on November 2, 2009
5. Microfluidics International Corporation Announces Second Quarter 2009 Financial Results
6. Microfluidics International Corporation to Report Second Quarter 2009 Financial Results on August 11, 2009
7. Particle Sciences and Microfluidics Collaborate to Share Formulation and Nanotechnology Expertise for Pharmaceutical Drug Product Development, Analysis and Commercialization
8. Nanopoint Applies CE Mark to Its cellTRAY(R) Imaging and Microfluidics Systems
9. Microfluidics Expands Distributorship in Japan with Exclusive POWREX Partnership to Meet Increased Demand in Pharmaceutical, Biotechnology and Energy Industries
10. GEN Reports on Growing Reliance on Microfluidics Technology
11. RainDance Technologies to Present Sequence Enrichment Using Droplet-Based Microfluidics Workshop at ASHG 2008
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Microfluidics Introduces Revolutionary Bottom-up Technology as a Platform for Continuous Pharmaceutical Manufacturing 
(Date:5/26/2017)... ... May 25, 2017 , ... Throughout this webinar, participants will ... process development and economic goals were achieved in both industry and academic settings. ... system, along with techniques for scaling production of mesenchymal stem cells (MSCs) and ...
(Date:5/24/2017)... BOUNTIFUL, Utah (PRWEB) , ... May 24, 2017 ... ... announces the selection and implementation of CLEARAS Water Recovery’s Advanced Biological Nutrient Recovery ... a key component of a $24 million plant upgrade to sustainably meet current ...
(Date:5/24/2017)... May 23, 2017 As Ebola resurfaces in the ... deaths and 20 suspected cases now reported, a new analysis ... database, showed a correlation between the 2014 and 2017 outbreaks ... rose sharply in 2012-13, which preceded the 2014 outbreak. An ... Ebola gene Replikin counts in 2014-15, which again precedes the ...
(Date:5/23/2017)... ... May 23, 2017 , ... Genedata, a ... anniversary, marking the occasion with a strong presence at Bio-IT World Conference & ... further extends an invitation to all attendees to view posters on the ...
Breaking Biology Technology:
(Date:4/5/2017)... 2017  The Allen Institute for Cell Science today ... one-of-a-kind portal and dynamic digital window into the human ... first application of deep learning to create predictive models ... and a growing suite of powerful tools. The Allen ... future publicly available resources created and shared by the ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/29/2017)... 2017  higi, the health IT company that operates ... America , today announced a Series B investment ... EveryMove. The new investment and acquisition accelerates higi,s strategy ... transform population health activities through the collection and workflow ... higi collects and secures data today on behalf of ...
Breaking Biology News(10 mins):